跳至主要内容
临床试验/NCT03911427
NCT03911427已完成不适用

Impact of Oat Product on LDL Cholesterol in Healthy Men and Women With Elevated LDL-cholesterol

PepsiCo Global R&D1 个研究点 分布在 1 个国家目标入组 207 人开始时间: 2019年4月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
207
试验地点
1
主要终点
Change in fasting serum LDL-cholesterol

研究概览

简要总结

The primary objective is to assess the effect of an oat ingredient provided over 4 weeks on serum LDL cholesterol in men and women with elevated LDL-cholesterol compared to a placebo.

Secondary endpoints are fasting serum total- and HDL-cholesterol, non-HDL-cholesterol, triglycerides, glucose, insulin, glycated albumin, HOMA-IR and Framingham risk score

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Fasting LDL cholesterol 116-193 mg/dl (3-5 mmol/L)
  • •Males and non-pregnant, non-lactating females 18-65 years
  • •Agree to consume the investigational product three times daily for the duration of the study
  • •BMI 18.5 to 39.9 kg/m2
  • •Blood pressure <160/100 mmHg
  • •Fasting triglycerides <4.0 mmol/L
  • •Fasting serum glucose <126mg/dL (<7 mmol/L)
  • •Serum urea and creatinine < 1.8 times upper limit of normal (ULN)
  • •Serum aspartate aminotransaminase (AST), alanine aminotransferase (ALT) and gamma-glutamyl transferase (GGT) < 2 times ULN
  • •Hemoglobin > 0.9 times lower limit of normal and < 1.1 times ULN
  • •Have a stable body weight (<7 kg change) over the past 3-months
  • •Absence of health conditions that would prevent fulfillment of study requirements

排除标准

  • •Pregnancy, breastfeeding or planning to be pregnant
  • •Allergy or sensitivity to study product ingredients
  • •Dislike description of study product
  • •Diet containing ≥15% of energy from saturated fat
  • •Consuming >20g fiber/per 1000 Kcal or >40g fiber/day (including soluble fiber supplements)
  • •Consumption of more than 2 drinks of alcohol per day, or more than 14 drinks per week
  • •Extreme dietary habits
  • •Smoking >5 cigarettes or equivalent per day
  • •Use of cholesterol lowering medication or prescription drug or for treating diabetes mellitus within 4 weeks of randomization
  • •Active major gastrointestinal disorder
  • •Major trauma or hospitalization for a medical condition or major surgical event within 6 months of randomization
  • •History of cancer within two years or randomization, except for non-melanoma skin cancer
  • •Any condition or substance use which might, in the opinion of the PI, make participation dangerous for the participant, lead to poor attendance or compliance or affect the results

研究组 & 干预措施

Powder Mix 1

Experimental

Oat powder product, mixed with water

干预措施: Active oat beverage (Other)

Powder Mix 2

Placebo Comparator

Brown rice milk powder product, mixed with water

干预措施: Control rice beverage (Other)

结局指标

主要结局

Change in fasting serum LDL-cholesterol

时间窗: Baseline vs. Week 4

Reduction in mmol/L is a better outcome and \>=5% reduction would be significant

次要结局

  • Change in fasting serum HDL cholesterol(Baseline vs. Week 4)
  • Change in fasting non-HDL-cholesterol(Baseline vs. Week 4)
  • Change in fasting triglycerides(Baseline vs. Week 4)
  • Change in fasting glucose(Baseline vs. Week 4)
  • Change in fasting insulin(Baseline vs. Week 4)
  • Change in fasting glycated albumin(Baseline vs. Week 4)
  • Change in fasting HOMA-IR(Baseline vs. Week 4)
  • Change in Framingham risk score(Baseline vs. Week 4)
  • Change in fasting serum total cholesterol(Baseline vs. Week 4)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验